Who
James Daniel Rudyk
Director
Company insider
Files Form 4 as: Director, Cronos Group.
In numbers
- Trades disclosed
- 8
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 7 Aug 2020
- Last trade
- 6 Aug 2026
- Last filed
- 7 Aug 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Aug 2026filed 7 Aug 2026 | CRON Cronos Groupoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —48,859.93 at $0.00 | filing |
| 6 Aug 2026filed 7 Aug 2026 | CRON Cronos Groupoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —48,859.93 at $0.00 | filing |
| 7 Aug 2025filed 11 Aug 2025 | CRON Cronos Groupoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —66,079.3 at $0.00 | filing |
| 8 Aug 2024filed 12 Aug 2024 | CRON Cronos Groupoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —64,655.17 at $0.00 | filing |
| 8 Aug 2023filed 10 Aug 2023 | CRON Cronos Groupoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —85,315.68 at $0.00 | filing |
| 8 Nov 2022filed 10 Nov 2022 | CRON Cronos Groupoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —53,763.44 at $0.00 | filing |
| 9 Aug 2021filed 11 Aug 2021 | CRON Cronos Groupoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —16,304.34 at $0.00 | filing |
| 7 Aug 2020filed 11 Aug 2020 | CRON Cronos Groupoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —19,280.2 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.